Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AB BioTechnologies to Build a New GMP Mfg. Facility | Contract Pharma
Breaking News

AB BioTechnologies to Build a New GMP Mfg. Facility

Will offer service for formulating, filling, freeze-drying and packaging injectable drugs for clinical trials

AB BioTechnologies has unveiled plans to invest $10.5 million to construct and equip a new 23,000 square foot manufacturing facility in Bloomington, IN, and create up to 33 jobs by 2020. The company will add manufacturing services for formulating, filling, freeze-drying, and packaging injectable drugs for clinical trial studies.

“This is a fantastic opportunity for AB BioTechnologies, Bloomington, Monroe County, and the state of Indiana,” said Jeff Schwegman, founder and chief executive officer, AB BioTechnologies. “We are one of only a handful of companies in the world that will offer all of these services in a small, nimble company format, and Monroe County is the perfect place for us to expand. The presence of a locally skilled workforce and access to graduates from Indiana University and Ivy Tech will assist us in hiring a competent workforce.”

AB BioTechnologies was founded in 2008 and has expanded into an internationally-recognized drug development company in the pharmaceutical industry. With the addition of its contract manufacturing services, the company will be able to shorten the time it takes to transfer a drug from concept to the clinic.

Visit AB BioTechnologies at Interphex Booth 1539.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters